University of Pittsburgh Medical Center Show Story highlights In a small trial, an herb long used in traditional Indian medicine, given along with regular medications, helped patients whose schizophrenia symptoms were worsening. A small clinical trial reported July 10 in the Journal of Clinical Psychiatry suggests that patients with schizophrenia whose symptoms have recently worsened may benefit from taking a medicinal herb called ashwagandha in addition to their regular medications. Ashwagandha, or Withania somnifera, has been used as a traditional medicine in India for thousands of years. In a randomized study involving 66 patients, it was more effective than a placebo at reducing the “negative” and other general symptoms of schizophrenia as well as patients’ stress over a 12-week treatment period. The negative symptoms of schizophrenia include social withdrawal, poverty of speech and difficulty showing emotions. These tend to be the symptoms that patients and families say are most disruptive to their lives, and they are harder to treat than the disorder’s “positive” symptoms—hallucinations, delusions, and other disturbances in thinking. The latter are successfully managed in many patients with currently available antipsychotic medicines. K.N. Roy Chengappa, M.D., FRCPC, a 2007 and 2004 Brain & Behavior Research Foundation (BBRF) Independent Investigator at the University of Pittsburgh Medical Center, led the study investigating ashwagandha’s effects. He and his team, including 2004 BBRF Young Investigator Jaspreet S. Brar, MBBS, Ph.D., also at the University of Pittsburgh Medical Center, were hopeful that it might help patients with schizophrenia because the herb is thought to have anti-inflammatory and immune system-modulating effects. Some scientists suspect excessive inflammation contributes to the symptoms of schizophrenia. Participants in the study were in their mid-to-late 40s and had been living with schizophrenia for more than 20 years. All were taking antipsychotic medications, and all had experienced recent exacerbations in their symptoms. During the clinical trial, they continued their regular medications and also took either an ashwagandha extract or a placebo each day, for 3 months. Dr. Chengappa and his colleagues began evaluating the effects of the treatment after two weeks. Beginning at 4 weeks and through the end of the 12-week study, patients receiving ashwagandha exhibited significantly greater reductions in negative symptoms than those taking the placebo. They also experienced a greater reduction in general psychiatric symptoms, such as depression and anxiety. Ashwagandha had no significant effect on patients’ positive schizophrenia symptoms. Side-effects were transient and mild, sedation being more common in those taking ashwagandha than placebo, Dr. Chengappa says. Related ArticlesDonate NowDonations are welcome
Archive: Full List of News on Complimentary Treatments for Schizophrenia
This new form of schizophrenia treatment has resulted in lower relapse rates and progressively better social functioning over 3 years, at least for people able to live with family members and meet basic survival needs, contend social worker Gerard E. Hogarty of the University of Pittsburgh School of Medicine and his colleagues. Cognitive Behavioral Therapy (CBT) has been judged by the Cochrane review as potentially positive for people with schizophrenia, stating that evidence suggests " that it [CBT] may well be of value, at least in the short term. Cognitive behavioural therapy should be further evaluated in various clinical settings and comparing effects for both expert and less skilled practitioners." Source; Cochrane Review Family therapy and assertive community treatment have clear effects on the prevention of psychotic relapse and rehospitalization. However, these treatments have no consistent effects on other outcome measures (e.g., pervasive positive and negative symptoms, overall social functioning, and ability to obtain competitive employment). Social skills training improves social skills but has no clear effects on relapse prevention, psychopathology, or employment status. Supportive employment programs that use the place-and-train vocational model have important effects on obtaining competitive employment. Some studies have shown improvements in delusions and hallucinations following cognitive behavior therapy. Preliminary research indicates that personal therapy may improve social functioning. Research suggests that relatively simple, long-term psychoeducational family therapy should be available to the majority of persons suffering from schizophrenia. Assertive community training programs ought to be offered to patients with frequent relapses and hospitalizations, especially if they have limited family support. Patients with schizophrenia can clearly improve their social competence with social skills training, which may translate into a more adaptive functioning in the community. For patients interested in working, rapid placement with ongoing support offers the best opportunity for maintaining a regular job in the community. Cognitive behavior therapy may benefit the large number of patients who continue to experience disabling psychotic symptoms despite optimal pharmacological treatment. (Source - psychosocial treatment, 2001 - see below) Glycine Therapy Glycine (an amino acid sold as a dietary supplement) has been a subject of research for over 15 years as a potential treatment for the negative symptoms of schizophrenia. Only a handful of human clinical trials with fewer than 50 people in each trial, have been completed (though one trial with 150 people has recently completed and has not yet been published). The trials published to date are reporting that the results have been quite positive, showing a significant reduction (averaging around 24%) in negative and cognitive symptoms based on the PANSS (Positive and Negative Schizophrenia Symptoms) scale. The clinical trials have shown that Glycine did not help people who are taking Clozapine, but it did help (in reducing negative symptoms) in people who were taking risperidone (Risperdal), and olanzapine (Zyprexa). The clinical trials suggest that the optimal dosage may be in the range of 30 grams to 60 grams a day. The biggest downside to taking glycine seems to be upset stomach and nausea which, researchers tell us, is quite common in people who take 60 grams of glycine a day for a month or two. Approaches used by the researchers to minimize this problem have been to start at lower doses (e.g. 5 to 10 grams split into two doses per day) and then to slowly phase up to higher doses over a period of weeks. Also - taking it after meals may assist in reducing side effects. One hypothesis of schizophrenia pathology suggests that NMDA-receptor disfunction (a special kind of glutamate receptor in the brain) may contribute to disordered synapses and brain atrophy, which ultimately result in the visible symptoms. Glycine may turn out to be a very beneficial supplemental treatment (when added to standard antipsychotic medications) for some people with schizophrenia. We hope to see longer and larger trials for glycine supplemental treatments. Talk with your doctor if you think you may benefit (review the report below for information on what glycine does and who it might help). See special report below for more information:
One reliable provider we are familiar in the USA and that we've had good experiences with is the Internet-store www.iherb.com - and specifically products from the "NOW Foods" company. Other leading companies that are known to have good manufacturing quality processes include Twinlab. We have no affiliation with either of these organizations. (Please note that there are no studies the schizophrenia researchers we are in contact with are aware of that support the idea that any type of vitamin or fatty acid (EFA) will cure schizophrenia. There are currently no cures for schizophrenia.) Supporting Research (a sample):
We could only find a single study on this topic - so it remains to be seen if this approach to therapy proves effective in larger, more rigorous studies. It seems that a calm and friendly dog (not a puppy that requires a lot of attention) could provide good companionship for people who have schizophrenia and don't socialize much. Additional TMS validation studies are needed and are underway. For more information, or to participate in the studies, contact Yale University PRIME TMS Research. or Other Groups working with TMS.
Chinese herbal medicine for schizophrenia In January, 2006 The Cochrane Review (a leading medical publisher) published a review article of all the studies that have been done so far on chinese herbal medicine use in treatment for schizophrenia. In their review article they stated:
Vitamin B6 - Vitamin B6 has also in the past been claimed to be a "cure" for schizophrenia (wrongly, as the data below indicates). As you should expect by now - if anyone makes any claims about a cure for schizophrenia - ask for some 3rd party validation studies from the major schizophrenia research centers around the world. Relevant Information and Research: Relevant Information and Research:
What helps negative symptoms of schizophrenia?Pharmacologic Treatment. Antipsychotic medication is the cornerstone of treatment for acute psychotic episodes, improving symptoms of schizophrenia in 81% of patients with first episode schizophrenia on average and improving symptoms of chronic schizophrenia in 51% of patients.
What natural herbs help with schizophrenia?Some natural herbs, like ginseng and ashwagandha, have been found to be beneficial in controlling the symptoms and improving the overall well-being of schizophrenia patients.
Can negative symptoms of schizophrenia go away?Though less obvious than positive symptoms like hallucination and delusions, negative symptoms can be just as hard to cope with. Treating negative symptoms is a challenge. But with a combination of drug therapy and psychotherapy, schizophrenia can be managed.
Is there a natural supplement for schizophrenia?B vitamins.
A large review of over 800 patients found that people who took high-dose B-vitamins like B6, B8, and B12 in addition to their medications significantly reduced symptoms of schizophrenia, compared with those who took medicines alone.
|